Skip to content

Clinical trials

Phase 2 Anemia, Iron-Deficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Iron-Deficiency Phase: Phase 2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20111
20121
20141
20172
20181
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
American Regent, Inc.2
AMAG Pharmaceuticals, Inc.1
Auerbach Hematology Oncology Associates P C1
Keryx Biopharmaceuticals1
M.D. Anderson Cancer Center1
Mayo Clinic1
MegaPro Biomedical Co. Ltd.1
NYU Langone Health1
University of Washington1
Wayne State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Iron-Deficiency11
Anemia3
Iron Deficiencies3
Renal Insufficiency, Chronic2
Gastrointestinal Stromal Tumors1
Hypoxia1
Inflammatory Bowel Diseases1
Kidney Diseases1
Liver Diseases1
Premature Birth1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.